N-Arachidonyl Maleimide (NAM) is primarily used in biochemical research to study the endocannabinoid system and its interactions with various biological pathways. It acts as a selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for breaking down endocannabinoids like anandamide. By inhibiting FAAH, NAM helps increase the levels of endocannabinoids in the body, making it a valuable tool for investigating the physiological and pharmacological roles of these signaling molecules. Researchers utilize NAM to explore its potential therapeutic effects in conditions such as pain, inflammation, anxiety, and neurodegenerative disorders. Additionally, it serves as a useful compound in the development of targeted therapies aimed at modulating the endocannabinoid system for medical applications.